• Bookmarks

    Bookmarks

  • Concepts

    Concepts

  • Activity

    Activity

  • Courses

    Courses


Immunological rejection is the process by which a recipient's immune system attacks a transplanted organ or tissue, recognizing it as foreign and potentially leading to transplant failure. This response is mediated by the immune system's recognition of non-self antigens on the graft, triggering a complex series of immune reactions aimed at destroying the perceived threat.
An alloantigen is an antigen that is recognized as foreign by the immune system of another individual of the same species, often leading to an immune response. This concept is crucial in the context of organ transplantation and blood transfusion, where alloantigen mismatches can lead to rejection or complications.
The major histocompatibility complex (MHC) is a set of cell surface proteins essential for the acquired immune system to recognize foreign molecules, which in turn determines histocompatibility and immune response. MHC molecules present peptide fragments to T cells, and their variability is crucial for the immune system's ability to adapt to a wide array of pathogens.
T-cell activation is a crucial process in the adaptive immune response, where T-cells recognize and respond to antigens presented by antigen-presenting cells. This activation requires two signals: antigen recognition by the T-cell receptor and a co-stimulatory signal, leading to T-cell proliferation and differentiation into effector cells.
Cytokine release is a critical immune response mechanism where signaling molecules are secreted by cells to communicate and coordinate actions during inflammation and infection. Dysregulation of this process can lead to Cytokine release syndrome, a potentially life-threatening condition characterized by excessive immune activation.
Hyperacute rejection is a severe immune response that occurs within minutes to hours after transplanting an organ, primarily due to pre-existing antibodies in the recipient's blood that recognize the donor organ as foreign. This immediate rejection is characterized by thrombosis and necrosis of the transplanted tissue, making it a critical concern in organ transplantation.
Acute rejection is an immune response that occurs shortly after an organ transplant, where the recipient's immune system attacks the transplanted organ, leading to potential organ failure. It is a critical condition that requires prompt diagnosis and treatment to preserve the function of the transplanted organ and improve patient outcomes.
Chronic rejection is a long-term immune response against a transplanted organ, leading to progressive deterioration of graft function over months to years. It is characterized by fibrosis and vascular changes, and remains a significant challenge in transplantation medicine due to its complex and multifactorial nature.
Immunosuppression is the deliberate or incidental reduction of the immune system's efficacy, often used to prevent rejection in organ transplantation or to treat autoimmune diseases. While it can prevent the immune system from attacking the body or transplanted organs, it also increases susceptibility to infections and malignancies.
Graft-versus-Host Disease (GVHD) is a medical condition that occurs when donor immune cells attack the recipient's body following a stem cell or bone marrow transplant. It is a major complication that can affect multiple organs and requires careful management to balance the beneficial graft-versus-tumor effect with the harmful immune response against the host's tissues.
HLA matching is a critical process in organ and bone marrow transplantation that involves comparing the human leukocyte antigen (HLA) markers of the donor and recipient to minimize the risk of transplant rejection. The closer the match between the HLA markers, the lower the likelihood of immune-mediated complications, enhancing the success rate of the transplant procedure.
Antibody-mediated rejection (AMR) is a form of transplant rejection where the recipient's immune system produces antibodies that specifically target and damage the donor organ, leading to graft dysfunction and potential loss. It is characterized by the presence of donor-specific antibodies, complement activation, and histological evidence of tissue injury in the transplanted organ.
Immune tolerance is the immune system's ability to recognize and not attack the body's own cells and harmless substances, preventing autoimmune diseases and allergies. This process involves complex mechanisms that ensure self-tolerance and prevent immune responses against beneficial or neutral antigens.
Xenotransplantation involves the transplantation of living cells, tissues, or organs from one species to another, often from animals to humans, to address the shortage of human organs available for transplantation. This practice raises significant ethical, immunological, and zoonotic concerns, necessitating rigorous research and regulatory frameworks to ensure safety and efficacy.
Graft integrity refers to the structural and functional soundness of a graft post-transplantation, ensuring it performs as intended without rejection or failure. It is crucial for the success of transplantation procedures, requiring meticulous surgical technique, compatibility matching, and post-operative care to maintain.
3